T3D Therapeutics Announces Results from the Phase 2 of T3D-959
03 Nov 2023 //
PR NEWSWIRE
T3D Selected to Present Topline Results from Phase 2 PIONEER Study of T3D-959
03 Oct 2023 //
PR NEWSWIRE
T3D`s Begins Enrollment in the PIONEER Phase 2 Clinical Trial of T3D-959
11 Feb 2020 //
BUSINESSWIRE